Coordinating care, closing gaps, and improving patient outcomes at scale in obesity and MASLD/MASH
Picture a system where at-risk patients are flagged for early intervention, where primary care has the tools to act, and where coordinated, multidisciplinary care is delivered at scale. For most organizations, that picture is blocked by fragmented care and siloed workflows.
It does not have to stay that way. With the right pathways and EHR support, health systems can shift the work earlier, reduce avoidable cost and improve outcomes for populations with obesity and MASLD/MASH.
The evidence is direct. Sixty to seventy-five percent of patients with any one of the five most common risk factors have MASLD. Costs ran 14 to 54% higher in patients with MASH and a cardiometabolic comorbidity than in those without. Patients with a FIB-4 of 2.67 or higher faced roughly 2.5 times higher all-cause mortality.
This report, built from a roundtable of health system executives, shows how leaders are responding.
Learnings:
It does not have to stay that way. With the right pathways and EHR support, health systems can shift the work earlier, reduce avoidable cost and improve outcomes for populations with obesity and MASLD/MASH.
The evidence is direct. Sixty to seventy-five percent of patients with any one of the five most common risk factors have MASLD. Costs ran 14 to 54% higher in patients with MASH and a cardiometabolic comorbidity than in those without. Patients with a FIB-4 of 2.67 or higher faced roughly 2.5 times higher all-cause mortality.
This report, built from a roundtable of health system executives, shows how leaders are responding.
Learnings:
- The high prevalence of multimorbidity in populations with obesity and MASLD/MASH necessitates multidisciplinary care team coordination
- Service lines can lead adherence to standardized screening protocols within a collaborative framework
- With greater support, primary care can initiate the timely management of obesity and MASLD/MASH
- HIT solutions may help facilitate earlier screening and intervention at scale for populations at risk of MASLD and MASH
Please fill out the form to download the whitepaper.